Literature DB >> 11569784

Occult metastases in sentinel nodes of 200 patients with operable breast cancer.

K Dowlatshahi1, M Fan, J M Anderson, K J Bloom.   

Abstract

BACKGROUND: Up to 30% of patients with operable breast cancer and negative regional lymph nodes experience disease recurrence within 10 years. Serial sectioning and immunohistochemical staining of these nodes have revealed 9% to 30% occult metastases.
METHODS: Sentinel nodes from 200 patients with T1 and T2 invasive breast carcinoma were step-sectioned at 2- to 3-mm intervals, fixed in 10% formalin, and embedded in paraffin. Sections were taken from the face of the blocks and stained with hematoxylin and eosin (H&E). The blocks were then cut completely, and sections at .25-mm intervals were stained with cytokeratin and examined.
RESULTS: Tumor metastases were found in 34 patients when the sentinel nodes were examined at 2- to 3-mm intervals and in an additional 51 patients when the nodes were sectioned in their entirety at .25-mm intervals and stained with cytokeratin, bringing the total number of patients with metastases to 85. Of the 51 patients whose metastases were detected by 2- to 3-mm sectioning and cytokeratin staining, 27 had isolated tumor cells and 24 had clusters of innumerable malignant cells, all of which were visualized and confirmed by H&E staining of the adjacent sections.
CONCLUSIONS: Histologic examination of sentinel nodes of patients with invasive breast cancer sectioned at 2- to 3-mm intervals and stained with H&E significantly underestimates nodal metastases. Sectioning of the entire sentinel nodes at .25-mm intervals and staining with cytokeratin detects metastases as either isolated cells or as clusters.

Entities:  

Mesh:

Year:  2001        PMID: 11569784     DOI: 10.1007/s10434-001-0675-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

Review 1.  Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis.

Authors:  John Backus; Todd Laughlin; Yixin Wang; Robert Belly; Robert White; Jon Baden; C Justus Min; Ann Mannie; Lorraine Tafra; David Atkins; Kathryn M Verbanac
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

3.  An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.

Authors:  S Abdul-Rasool; S H Kidson; E Panieri; D Dent; K Pillay; G S Hanekom
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

Review 4.  Current status of sentinel lymph-node biopsy in patients with breast cancer.

Authors:  Gang Cheng; Stephanie Kurita; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-11       Impact factor: 9.236

5.  Supervised automated microscopy increases sensitivity and efficiency of detection of sentinel node micrometastases in patients with breast cancer.

Authors:  W E Mesker; H Torrenga; W C R Sloos; H Vrolijk; R A E M Tollenaar; P C de Bruin; P J van Diest; H J Tanke
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

6.  Intracellular esterase activity in living cells may distinguish between metastatic and tumor-free lymph nodes.

Authors:  Elena Afrimzon; Assaf Deutsch; Yana Shafran; Naomi Zurgil; Judith Sandbank; Itzhak Pappo; Mordechai Deutsch
Journal:  Clin Exp Metastasis       Date:  2008-01-16       Impact factor: 5.150

7.  Impact of Post-Mastectomy Radiation Therapy for Sentinel Lymph Node Micrometastases in Early-Stage Breast Cancer Patients.

Authors:  Hua Luo; Ou Ou Yang; Jun Ling He; Tian Lan
Journal:  Med Sci Monit       Date:  2022-01-30

8.  Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer.

Authors:  Mike Visser; Mehdi Jiwa; Anja Horstman; Antoinette A T P Brink; Rene P Pol; Paul van Diest; Peter J F Snijders; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.